Madrona leads $60M investment into AI-powered drug discovery company Terray Therapeutics
GeekWire
FEBRUARY 15, 2022
-based Terray Therapeutics , which combines nanotechnology with artificial intelligence, has raised $60 million in a Series A funding round led by Seattle’s Madrona Venture Group. Terray’s chips are fit with millions of molecules that can be used for drug-target screening, with the resulting data fed into machine learning models.
Let's personalize your content